Medplus Subsidiary Receives 7-Day Drug License Suspension in Andhra Pradesh

Med Plus Health Services Limited announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a Drug License for a store located in Andhra Pradesh. The ...

Med Plus Health Services Limited announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a Drug License for a store located in Andhra Pradesh. The suspension is for a period of seven days and affects the store situated at Gollapudi One Center. The order was issued by the Assistant Director, District Sales Licensing Authority, Drugs Control Administration, Vijayawada, Andhra Pradesh. The suspension is effective upon receipt of the order, which was dated December 31, 2025. This action was taken under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The company estimates a potential revenue loss of approximately ₹2.10 lakhs due to this suspension. This information is being shared as an update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Medplus Health Services Limited in the news today?

Medplus Health Services Limited (MEDPLUS) is in the news due to the announcement details a suspension of a drug license for a subsidiary's store, which is a negative development for the company's operations and potentially its revenue.

Other Regulatory FilingsLitigation UpdatesOther Company Updates
Medplus Health Services LimitedMEDPLUShttps://prysm.fi/v2/analyze/MEDPLUS

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Medplus Subsidiary Receives 7-Day Drug License Suspension in Andhra Pradesh

January 1, 2026, 09:05 AM

AI Sentiment Analysis

Top Queries to Ask About Medplus Health Services Limited

More Details on This News

Med Plus Health Services Limited announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a Drug License for a store located in Andhra Pradesh. The suspension is for a period of seven days and affects the store situated at Gollapudi One Center.

The order was issued by the Assistant Director, District Sales Licensing Authority, Drugs Control Administration, Vijayawada, Andhra Pradesh. The suspension is effective upon receipt of the order, which was dated December 31, 2025. This action was taken under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945.

The company estimates a potential revenue loss of approximately ₹2.10 lakhs due to this suspension. This information is being shared as an update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Medplus Health Services Limited

Discover more trending news on Prysm

View All